middle.news
Resmed Posts 11% Revenue Growth with Margin Gains and U.S. Expansion Plans
8:44am on Friday 1st of May, 2026 AEST
•
Healthcare
Read Story
Resmed Posts 11% Revenue Growth with Margin Gains and U.S. Expansion Plans
8:44am on Friday 1st of May, 2026 AEST
Key Points
11% revenue growth to $1.43 billion
290 basis points gross margin expansion
21% non-GAAP EPS increase to $2.86
Operating cash flow of $554 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE